China Pharma (NYSE:CPHI – Get Free Report) announced its quarterly earnings data on Wednesday. The company reported ($0.09) earnings per share for the quarter, reports. China Pharma had a negative return on equity of 54.31% and a negative net margin of 55.42%. The business had revenue of $0.93 million during the quarter.
China Pharma Stock Up 7.6 %
NYSE:CPHI traded up $0.01 during midday trading on Friday, reaching $0.20. 278,086 shares of the stock traded hands, compared to its average volume of 360,754. The company has a fifty day moving average of $0.24 and a 200 day moving average of $0.32. China Pharma has a 12 month low of $0.17 and a 12 month high of $1.77. The company has a current ratio of 0.89, a quick ratio of 0.25 and a debt-to-equity ratio of 0.17.
Analyst Upgrades and Downgrades
Separately, StockNews.com started coverage on shares of China Pharma in a report on Saturday, August 10th. They set a “hold” rating for the company.
China Pharma Company Profile
China Pharma Holdings, Inc develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China. The company provides products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions.
Featured Stories
- Five stocks we like better than China Pharma
- Why Invest in 5G? How to Invest in 5G Stocks
- Bumble’s Valuation Hits an All-Time Low, Can Its Fortunes Change?
- Trading Stocks: RSI and Why it’s Useful
- MarketBeat Week in Review – 8/12 – 8/16
- About the Markup Calculator
- JD.com Earnings Surprise: China’s Outlook Better Than Expected
Receive News & Ratings for China Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for China Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
